Keybanc Maintains Overweight on West Pharmaceutical Servs, Raises Price Target to $375

Keybanc analyst Paul Knight maintains West Pharmaceutical Servs (NYSE:WST) with a Overweight and raises the price target from $315 to $375.

Keybanc analyst Paul Knight maintains West Pharmaceutical Servs (NYSE:WST) with a Overweight and raises the price target from $315 to $375.

Total
0
Shares
Related Posts